{"result": {"id": "chatcmpl-352", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**RANIBIZUMAB** is an anti-VEGF drug used in the treatment of eye diseases. It appears to be as safe and effective as **vacizumab**, another anti-VEGF drug.  This medication is often used to address vascular leakage, a condition that can lead to vision problems. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743087984, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 64, "prompt_tokens": 223, "total_tokens": 287, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"RANIBIZUMAB\"\nDescription List: [\"A drug that appears to be as safe and effective as vacizumab\\nA drug that appears to be as safe and effective as vacizumab)**Relationships:**  (\\\"relationship\\\"\", \"Another drug used in the study\", \"Anti-VEGF drug\", \"Ranibizumab is a drug used in the treatment of eye diseases\", \"Ranibizumab is a drug used to treat vascular leakage\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_ae56ab1bf35457a77d2ef3cfcdb91c69af511e191fdbdc4e03041823950e3161_v2"}